Skip to main content
Premium Trial:

Request an Annual Quote

Roche Grants PCR License to Idaho Technology

NEW YORK, Jan. 5 (GenomeWeb News) - Idaho Technology today has licensed non-exclusive worldwide access to Roche's PCR patents.


The Salt Lake City-based firm said the agreement provides it with rights to use the technology in in vitro diagnostic products. Terms of the license were not disclosed.


Idaho Technology makes instruments for pathogen detection, reagents, and thermocyclers, including the LightCycler, which Roche markets under an agreement signed between the firms in 1997.


The privately held firm also announced that it is registered with the US Food and Drug Administration to develop, manufacture, and sell analyte specific reagents for molecular diagnostic purposes.

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people over 65 or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.